NAMSW   $6.9653  3.96% Market Closed

NewAmsterdam Pharma Company NV
Total Cash 430.71M
totalCashPerShare 4.785
EBITDA -208.63M
Total Debt 562.00K
quickRatio 9.626
currentRatio 9.83
Total Revenue 7.42M
debtToEquity 0.145
Revenue/Share 0.085
ROA -0.27145
ROE -0.54077
grossProfits
freeCashflow -108.42M
operatingCashflow -188.63M
earningsGrowth
revenueGrowth 0.327
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -23.06933
profitMargins 0.0
enterpriseValue
forwardPE
floatShares 33.89M
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 4.304
Price To Book help_outline 1.51
earningsQuarterlyGrowth
netIncomeToCommon -229.40M
trailingEps
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 11
lastUpdated Sept. 17, 2024, 2:33 a.m.